In this study we observed that a DNA vaccine encoding a dimeric construct that targets hemagglutinin to antigen-presenting cells can induce an influenza-specific CD8+ T cell response, which in the context of antibody can lead to more rapid recovery from infection. The gene discussed is CD8A; the disease is infection.